LCN2 and cholangiocarcinoma: Further prospective multicentric studies, which should include a greater number of early-stage cholangiocarcinoma cases, need to be done to evaluate the roles of NGAL in early detection of cholangiocarcinoma, correlation with the grade of cholangiocarcinoma, and oncologic followup should be performed.